News / Press – Diomics

Home
|
Category: News / Press

A Human Antibody Nasal Spray Under Development Might Have Prevented White House Infections, Scientists At Diomics And Active Motif Say

Antibody Barrier in the Nasal Cavity Could Hold A Key to Curtailing Virus SpreadSAN ...

Diomics Announces Agreement with Department of Defense to Accelerate Development and Testing of Diocheck™ SARS-CoV-2 Immune Response Indicator Patch

Simple Skin Patch Empowers Individuals to Monitor for Immune Response to Help Stop COVID-19 ...

Diomics Aims to Nose Out Coronavirus Ahead of Vaccines With Nasal Spray That Delivers Monoclonal Antibody Protection

Unique Prophylactic Approach Couples IgG Antibodies from Active Motif with Diomics’ Proprietary Bioresorbable Polymer ...

Diomics Announces Development Of Diocheck™ Visual Antibody Indicator

Proprietary Diomat™ Technology Enables Long-Term Antibody Detection to Assist in COVID-19 MonitoringSAN DIEGO, CALIF., August ...

Diomics Corp. Announces Development of Intellectual Property and Patents Related to the Identification of Airborne Pathogens

DiomatTM Technology Can Identify Deadly Airborne Pathogens and be Deployed in Fixed Structures Such as ...

Diomics Corporation and University of California, Irvine Collaborate to Enable Cell Therapy Clinical Trial for Type 1 Diabetes

SAN DIEGO, CA, Jan. 02, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Diomics Corporation, a ...